Literature DB >> 29027564

Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.

Makoto Naganuma1, Nobuo Aoyama2, Tomohiro Tada3, Kiyonori Kobayashi4, Fumihito Hirai5, Kenji Watanabe6, Mamoru Watanabe7, Toshifumi Hibi8.   

Abstract

In Fig. 2(c) of this article, the length of the "95% CI difference bars" under the items labelled "Left-sided and Pancolitis" and "Left-sided" under the heading "Disease type" was corrected. The correct figure is shown in the following page.

Entities:  

Year:  2018        PMID: 29027564      PMCID: PMC6828090          DOI: 10.1007/s00535-017-1399-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  1 in total

1.  Author's reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?

Authors:  Makoto Naganuma
Journal:  J Gastroenterol       Date:  2018-06       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.